1 – 7 of 7
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study
(
- Contribution to journal › Article
- 2013
-
Mark
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study
(
- Contribution to journal › Article
-
Mark
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
(
- Contribution to journal › Article
- 2009
-
Mark
Rationale and design of Ferinject((R)) Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia
(
- Contribution to journal › Article
-
Mark
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
(
- Contribution to journal › Article
- 2008
-
Mark
A randomised trial of a pre-synaptic stimulator of DA(2)-dopaminergic and alpha(2)-adrenergic receptors on morbidity and mortality in patients with heart failure
(
- Contribution to journal › Article
- 2006
-
Mark
Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery disease.
(
- Contribution to journal › Article